Global Biobanking Market to Grow at a CAGR of 8.84% by 2021 - Emergence of Stem Cells Storage in Biobanks is a Key Market Trend - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Global Biobanking Market 2017-2021" report to their offering.

The global biobanking market to grow at a CAGR of 8.84% during the period 2017-2021.

The report, Global Biobanking Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

The latest trend gaining momentum in the market is emergence of stem cells storage in biobanks. The demand for stem cells storage in biobanks is growing phenomenally and is expected to have a positive impact on the market growth during the forecast period. The increasing use of biobanking in stem cell research is likely to improve access to novel therapeutic resources for a wider population. According to researchers, stem cells have the capability to address many unmet medical needs in areas such as cardiology and oncology.

According to the report, one of the major drivers for this market is increase in funding. The increase in government funding worldwide will increase the number of biobanks, and thereby drive market growth during the forecast period. Healthcare organizations are increasing funding to help establish more biobanks and to boost their capabilities.

Key vendors

  • Beckman Coulter
  • BioCision
  • Taylor-Wharton
  • Tecan Group
  • Thermo Fisher Scientific
  • VWR

Key Topics Covered:

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

PART 05: Biobanks: An overview

PART 06: Storage conditions

PART 07: Market landscape

PART 08: Biobank funding and financial stability

PART 09: Harmonization of biobanking

PART 10: Market segmentation by product

PART 11: Market segmentation by sample

PART 12: Geographical segmentation

PART 13: Market drivers

PART 14: Impact of drivers

PART 15: Market challenges

PART 16: Impact of drivers and challenges

PART 17: Market trends

PART 18: Vendor landscape

PART 19: Key vendor analysis

PART 20: Appendix

For more information about this report visit http://www.researchandmarkets.com/research/rz2x95/global_biobanking

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Biotechnology

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Biotechnology